NEW YORK, NY -- 06/21/07 --
China DongSheng International, Inc. (OTCBB: CDSG) (the "Company") announced today that DongSheng Weiye Science and
Technology Co. Ltd., the Company's wholly owned China-based operating
subsidiary, has received Good Manufacturing Practices (GMP) accreditation
(GB17405-1998) for its tablet, capsule, granule, soft gel and hard gel
health food products. The newly certified 4,800 M2 of production facilities
have already been put into production. The accreditation is good for four
years, starting as of May 9, 2007.
"We are very excited to have passed the vigorous inspection of the Jilin
Provincial Department of Health. This is yet another important landmark
development in our Company's history. It is the result of our Company's
consistent pursuit of higher manufacturing standards. With the new
production facilities and equipment put into use and the new GMP
certification, we are looking forward to further promoting our
nutraceutical and personal care products in the market," commented Aidong
Yu, Chairman and President of China DongSheng.
About China DongSheng International, Inc.
China DongSheng International, Inc., through its 100%-owned subsidiary,
Jilin Dongsheng Weiye Science and Technology Co., Ltd, is engaged in the
development and manufacture of nutritional supplements and personal care
products domestically in China. The Company sells these products through a
network marketing system with approximately 200,000 distributors and 2,500
retail outlets in twenty-six provinces throughout China.
Safe Harbor Statement
The statements contained herein that are not historical facts are
"forward-looking statements" within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements may be
identified by, among other things, the use of forward-looking terminology
such as "believes," "expects," "may," "will," "should," or "anticipates" or
the negative thereof or other variations thereon or comparable terminology,
or by discussions of strategy that involve risks and uncertainties. In
particular, our statements regarding the potential growth of the markets
are examples of such forward-looking statements. The forward-looking
statements include risks and uncertainties, including but not limited to,
general economic conditions and regulatory developments, not within our
control. The factors discussed herein and expressed from time to time in
our filings with the Securities and Exchange Commission could cause actual
results and developments to be materially different from those expressed or
implied by such statements. The forward-looking statements are made only as
of the date of this filing, and we undertake no obligation to publicly
update such forward-looking statements to reflect subsequent events or
circumstances.
Contact
Peter D. Zhou
China DongSheng International, Inc.
100 Wall Street, 15th Floor
New York, NY 10005
(212) 232-0120 ext 228
